ALX148
Showing 1 - 13 of 13
Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, ALX148, Doxorubicin)
Not yet recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 19, 2022
Microsatellite Stable Metastatic Colorectal Cancer Trial in Tucson, Aurora, New Brunswick (ALX148, Cetuximab, Pembrolizumab)
Recruiting
- Microsatellite Stable Metastatic Colorectal Cancer
- ALX148
- +2 more
-
Tucson, Arizona
- +2 more
Jul 28, 2022
Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular
Recruiting
- Aggressive B-Cell Non-Hodgkin Lymphoma
- +19 more
- CD47 Antagonist ALX148
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2022
Acute Myeloid Leukemia, AML, Adult Trial in United States (evorpacept, venetoclax, azacitidine)
Active, not recruiting
- Acute Myeloid Leukemia
- AML, Adult
- evorpacept
- +2 more
-
Chicago, Illinois
- +4 more
Jun 7, 2022
Metastatic Cancer, Solid Tumor, Advanced Cancer Trial in Korea, Republic of, United States (Evorpacept (ALX148), Pembrolizumab,
Active, not recruiting
- Metastatic Cancer
- +3 more
- Evorpacept (ALX148)
- +5 more
-
Denver, Colorado
- +9 more
Jul 20, 2022
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab)
Recruiting
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
-
Irvine, California
- +10 more
Nov 4, 2021
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab, Cisplatin/Carboplatin;
Recruiting
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
- Evorpacept
- +2 more
-
Irvine, California
- +10 more
Nov 4, 2021
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma Trial in Worldwide (Evorpacept (ALX148),
Recruiting
- Gastric Cancer
- +2 more
- Evorpacept (ALX148)
- +3 more
-
Anaheim, California
- +54 more
Jan 23, 2023
HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab
Recruiting
- HER2-positive Breast Cancer
- +17 more
- ALX148
- Fam-Trastuzumab Deruxtecan-Nxki
-
Chicago, Illinois
- +1 more
May 19, 2023